Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2024

10.01.2023 | Maternal-Fetal Medicine

Comparison of serum levels of cell adhesion molecules (E-selectin, P-selectin, ICAM-1, VCAM-1, LRG-1) in placental invasion and adhesion anomalies with patients with vaginal delivery and former cesarean

verfasst von: Rutkay Ersuz, Oya Soylu Karapınar, Serdar Doğan

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

It is aimed to be a technique that can be used for diagnosis and to prevent maternal deaths in cases where the serum levels of cell adhesion molecules are different in patients with abnormal placentation compared to healthy pregnant women.

Materials and methods

Patients between March 2020 and September 2021 were included in the study. While 56 patients, out of 153 cases formed the placental adhesion and/or localization anomaly group, 55 cases without placental adhesion anomaly (placental invasion anomaly and/or previa pathology) constituted the cesarean section group and 42 cases constituted the vaginal birth control group. Demographic characteristics and histories of 153 patients were questioned. I-CAM-1, V-CAM-1, E-Selectin, P-Selectin, LRG-1 levels were studied. The parameters measured by the ELISA method were studied in the Thermo Fisher Scientific Multiscan Go (Finland) device at the Hatay Mustafa Kemal University Medical Faculty Medical Biochemistry USA ELISA Laboratory. Wholehouse and One Way Anova analysis methods were used to compare the results.

Results

There were significant differences in E-Selectin, P-Selectin, ICAM-1 and LRG-1 values between the groups (p < 0.05). There was a significant difference between the vaginal birth (VB) and previa/percreata (PP) groups in terms of E-Selectin (p = 0.038). In terms of P-Selectin, there was a significant difference between the C/S and previa/percreata (PP) groups (p < 001). P-Selectin was higher in the previa/percreata (PP) group. There was a significant difference between the Vaginally birth (VB), C/S group (p = 0.041) and the vaginal birth (VB), previa/percreata (PP) group (p = 0.013) in terms of ICAM-1, but there was no significant difference between the C/S and previa/percreata (PP) groups. In terms of LRG-1, there was a significant difference between all 3 groups (p < 0.05).

Discussion

A recent study investigated the potential modulatory effects of trans-resveratrol (RSV), arginase and endothelial dysfunction biomarkers in patients with PE. Another reflection of endothelial dysfunction in PE is increased endothelial activation biomarkers such as intercellular adhesion molecule-1 (ICAM-1), von Willebrand factor (vWF), and Caspase-3 (CASP-3). The study, regarding vWF expression, the preeclampsia (PE) group showed higher levels compared to endothelial cells incubated with healty pregnant (HP) plasma [Bueno-Pereira et al 2022 Antioxidants 2111]. From this and similar studies, the hypothesis that the role of cell adhesion molecules in endothelial damage may be the underlying cause of invasion and location anomalies emerges. This hypothesis is the starting point of our study.

Conclusions

In our study, all adhesion molecules except V-CAM-1 were found to be significantly higher in the previa/percreata (PP) group. E-Selectin and LRG-1 adhesion molecules were found to be significantly higher even in C/S patients compared to normal delivery. As a result; these adhesion molecules can be studied as a marker in previa/percreata (PP) patients.
Literatur
1.
Zurück zum Zitat Dimitriadis E, Robb L, Liu Y, Enders A, Martin H, Stoikos C et al (2003) IL-11 and IL-11Rα immunolocalisation at primate implantation sites supports a role for IL-11 in placentation and fetal development. Reprod Biol Endocrinol 1(1):1–10CrossRef Dimitriadis E, Robb L, Liu Y, Enders A, Martin H, Stoikos C et al (2003) IL-11 and IL-11Rα immunolocalisation at primate implantation sites supports a role for IL-11 in placentation and fetal development. Reprod Biol Endocrinol 1(1):1–10CrossRef
2.
Zurück zum Zitat Rabia RZ, Chughtai HA, Zafar H, Ilyas S, Mujahid S, Bakar MA (2022) The incidence of placenta previa among women with subsequent pregnancy after previous cesarean sections. Obstet Gynaecol Res 5(3):158–161 Rabia RZ, Chughtai HA, Zafar H, Ilyas S, Mujahid S, Bakar MA (2022) The incidence of placenta previa among women with subsequent pregnancy after previous cesarean sections. Obstet Gynaecol Res 5(3):158–161
3.
Zurück zum Zitat Faiz A, Ananth C (2003) Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med 13(3):175–190CrossRefPubMed Faiz A, Ananth C (2003) Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med 13(3):175–190CrossRefPubMed
4.
Zurück zum Zitat Abuhamad A, editor Morbidly adherent placenta. Seminars in perinatology; 2013: Elsevier. Abuhamad A, editor Morbidly adherent placenta. Seminars in perinatology; 2013: Elsevier.
5.
Zurück zum Zitat Karapinar OS, Sahin H, Gozukara I, Sahin EA, Ozcan O, Sezgin B, et al. YKL-40 and fibronectin levels in patients with placental invasion anomaly. 2021. Karapinar OS, Sahin H, Gozukara I, Sahin EA, Ozcan O, Sezgin B, et al. YKL-40 and fibronectin levels in patients with placental invasion anomaly. 2021.
6.
Zurück zum Zitat Rosenberg T, Pariente G, Sergienko R, Wiznitzer A, Sheiner E (2011) Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet 284(1):47–51CrossRefPubMed Rosenberg T, Pariente G, Sergienko R, Wiznitzer A, Sheiner E (2011) Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet 284(1):47–51CrossRefPubMed
7.
8.
Zurück zum Zitat Silver RM (2015) Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol 126(3):654–668CrossRefPubMed Silver RM (2015) Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol 126(3):654–668CrossRefPubMed
9.
Zurück zum Zitat Nazneen S, Bukhari N (2022) Placenta Previa and the Associated Risk Factors. Pak J Med Health Sci 16(7):765 Nazneen S, Bukhari N (2022) Placenta Previa and the Associated Risk Factors. Pak J Med Health Sci 16(7):765
10.
Zurück zum Zitat Jauniaux E, Hussein AM, Elbarmelgy RM, Elbarmelgy RA, Burton GJ (2022) Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface. Am J Obstet Gynecol 226(2):243CrossRef Jauniaux E, Hussein AM, Elbarmelgy RM, Elbarmelgy RA, Burton GJ (2022) Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface. Am J Obstet Gynecol 226(2):243CrossRef
11.
Zurück zum Zitat Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR et al (2018) Placenta accreta spectrum. Am J Obstet Gynecol 219(6):B2–B16CrossRefPubMed Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR et al (2018) Placenta accreta spectrum. Am J Obstet Gynecol 219(6):B2–B16CrossRefPubMed
12.
Zurück zum Zitat Duzyj C, Buhimschi IA, Motawea H, Laky C, Cozzini G, Zhao G et al (2015) The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin. Placenta 36(6):645–651CrossRefPubMed Duzyj C, Buhimschi IA, Motawea H, Laky C, Cozzini G, Zhao G et al (2015) The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin. Placenta 36(6):645–651CrossRefPubMed
13.
Zurück zum Zitat Wehrum MJ, Buhimschi IA, Salafia C, Thung S, Bahtiyar MO, Werner EF et al (2011) Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol 204(5):411CrossRefPubMedCentral Wehrum MJ, Buhimschi IA, Salafia C, Thung S, Bahtiyar MO, Werner EF et al (2011) Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol 204(5):411CrossRefPubMedCentral
14.
Zurück zum Zitat Makrilia N, Kollias A, Manolopoulos L, Syrigos K (2009) Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest 27(10):1023–1037CrossRefPubMed Makrilia N, Kollias A, Manolopoulos L, Syrigos K (2009) Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest 27(10):1023–1037CrossRefPubMed
15.
Zurück zum Zitat Terekeci MH, Şahan B, Top C (2008) Hücre adezyon molekülleri. Assessment 62:70 Terekeci MH, Şahan B, Top C (2008) Hücre adezyon molekülleri. Assessment 62:70
16.
Zurück zum Zitat Güngören A, Bastacı FS, Gözükara İ (2021) Increased CA-125 levels in Placenta Previa. Sylwan 165:225–235 Güngören A, Bastacı FS, Gözükara İ (2021) Increased CA-125 levels in Placenta Previa. Sylwan 165:225–235
17.
Zurück zum Zitat Korkmazer E, Nizam R, Arslan E, Akkurt Ö (2019) Relationship between intercellular adhesion molecule-1 and morbidly adherent placenta. J Perinat Med 47(1):45–49CrossRef Korkmazer E, Nizam R, Arslan E, Akkurt Ö (2019) Relationship between intercellular adhesion molecule-1 and morbidly adherent placenta. J Perinat Med 47(1):45–49CrossRef
18.
Zurück zum Zitat Korkmazer E, Nizam R, Arslan E, Akkurt Ö (2018) Relationship between vascular cell adhesion molecule-1 and morbidly adherent placenta. J Gynecol Obstet Human Reprod 47(10):549–553CrossRef Korkmazer E, Nizam R, Arslan E, Akkurt Ö (2018) Relationship between vascular cell adhesion molecule-1 and morbidly adherent placenta. J Gynecol Obstet Human Reprod 47(10):549–553CrossRef
19.
Zurück zum Zitat Bueno-Pereira TO, Bertozzi-Matheus M, Zampieri GM, Abbade JF, Cavalli RC, Nunes PR et al (2022) Markers of endothelial dysfunction are attenuated by resveratrol in preeclampsia. Antioxidants 11(11):2111CrossRefPubMedPubMedCentral Bueno-Pereira TO, Bertozzi-Matheus M, Zampieri GM, Abbade JF, Cavalli RC, Nunes PR et al (2022) Markers of endothelial dysfunction are attenuated by resveratrol in preeclampsia. Antioxidants 11(11):2111CrossRefPubMedPubMedCentral
Metadaten
Titel
Comparison of serum levels of cell adhesion molecules (E-selectin, P-selectin, ICAM-1, VCAM-1, LRG-1) in placental invasion and adhesion anomalies with patients with vaginal delivery and former cesarean
verfasst von
Rutkay Ersuz
Oya Soylu Karapınar
Serdar Doğan
Publikationsdatum
10.01.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2024
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-023-06911-2

Weitere Artikel der Ausgabe 1/2024

Archives of Gynecology and Obstetrics 1/2024 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.